ALTERED SUBSTRATE PREFERENCE IN REPERFUSED HEARTS
ALTERED SUBSTRATE PREFERENCE IN REPERFUSED HEARTS
批准号:
2735368
负责人:
PAUL E WOLKOWICZ
金额:
$20.03万
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
已结题
起止时间:
1997-07-01 至 2001-06-30
中文摘要
描述(改编自申请人摘要):本申请
英文摘要
DESCRIPTION (Adapted from Applicant's Abstract): This application
investi-gates a marker of viability in post-ischemic hearts, altered
substrate preference. Hearts normally use exogenous long-chain fatty acids
(LC-FA) as the preferred substrate for energy production. LC-FA also may be
stored as triglycerides (TG) but storage of LC-FA occurs at a low rate in
normal hearts. As a result, the TG content of normal hearts is low.
Oxidation of alternate substrate, such as glucose also is low in normal
hearts. Viable post-ischemic myocardium demonstrates a pattern of substrate
preference different from normal hearts. Specifically, oxidation of glucose
and storage of LC-FA, a glycolysis-dependent process, are enhanced. These
changes increase the content of TG in viable post-ischemic myocardium, an
event that has been reported by histological, radionuclide, tomographic and
magnetic resonance imaging analyses. Despite the fact that enhanced LC-FA
storage is one hallmark of viable post-ischemic myocardium, little is known
about the relationship between LC-FA storage and altered substrate
preference in post-ischemic myocardium. Also, the underlying cause(s) of
altered substrate preference in post-ischemic myocardium is not known.
Consequently, the application has two goals. The first goal is to
quantitate thoroughly the altered substrate preference in isolated
post-ischemic rat hearts using 13C-magnetic resonance spectroscopy and
radionuclide technologies. The second goal is to determine the underlying
cause(s) for altered substrate preference using enzymatic analyses.
Accomplishing these goals will delineate the mechanism and importance of
enhanced LC-FA storage as a marker for myocardial viability in post-ischemic
hearts.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
ALTERED SUBSTRATE PREFERENCE IN REPERFUSED HEARTS
-
批准号:6184006
-
项目类别:
-
资助金额:$19.88万
-
财政年份:1997
-
负责人:PAUL E WOLKOWICZ
-
依托单位:
ALTERED SUBSTRATE PREFERENCE IN REPERFUSED HEARTS
-
批准号:2031179
-
项目类别:
-
资助金额:$17.9万
-
财政年份:1997
-
负责人:PAUL E WOLKOWICZ
-
依托单位:
ALTERED SUBSTRATE PREFERENCE IN REPERFUSED HEARTS
-
批准号:6030804
-
项目类别:
-
资助金额:$19.3万
-
财政年份:1997
-
负责人:PAUL E WOLKOWICZ
-
依托单位:
CARNITINE TRANSPORT IN NATURAL AND ARTIFICIAL MEMBRANE
-
批准号:3354744
-
项目类别:
-
资助金额:$9.15万
-
财政年份:1986
-
负责人:PAUL E WOLKOWICZ
-
依托单位:
国内基金
海外基金
基于DNA甲基化交互网络的癌症hallmark挖掘及其在癌症转移biomarker筛选中的应用
-
批准号:61602201
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2016
-
负责人:周雄辉
-
依托单位:
血清miRNAs成为一种新的biomarker在PD诊断中的价值和LRRK2基因调控的机制研究
-
批准号:81170309
-
项目类别:面上项目
-
资助金额:50.0万元
-
批准年份:2011
-
负责人:颜桥
-
依托单位:
非小细胞肺癌Biomarker的Imaging MS研究新方法
-
批准号:30672394
-
项目类别:面上项目
-
资助金额:30.0万元
-
批准年份:2006
-
负责人:陆豪杰
-
依托单位: